LAZARD ASSET MANAGEMENT LLC
Position in MRVI — Maravai Lifesciences Holdings, Inc.
CIK 1207017
NEW YORK, NY
Position in MRVI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,623,046
+$223,775 QoQ
Shares Held
420,360
-50.4% QoQ
Ownership
0.162%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 177 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 52%
Shared 0%
None 48%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LAZARD ASSET MANAGEMENT LLC holds $400,660,289 across 59 Biotechnology names. MRVI ranks #23 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
131,996 | $122,461,928 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
93,287 | $46,338,451 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
90,348 | $25,746,469 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,910 | $23,014,861 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
350,397 | $20,049,716 | |
| 6 | EXEL |
Exelixis, Inc.
|
343,029 | $18,664,207 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
69,588 | $16,768,620 | |
| 8 | INCY |
Incyte Corp
|
136,684 | $15,494,498 |
All Filings in MRVI
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,623,046 | 420,360 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,399,271 | 847,799 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,310,833 | 1,018,718 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,420,448 | 1,540,226 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,495,514 | 1,450,421 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,107,907 | 1,406,293 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,890,041 | 1,447,714 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,969,549 | 1,320,042 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,238,109 | 1,150,574 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,165,928 | 365,159 | Shares | Sole | 2024-07-09 | |
| 2023-12-31 | $37,648 | 5,748 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $38,140 | 3,814 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $45,431 | 3,655 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $130,992 | 9,350 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $47,551 | 3,323 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $1,021 | 40 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,869 | 101 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $3,562 | 101 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $13,072 | 312 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $17,273,705 | 351,950 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $71,722,227 | 1,718,721 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $119,795,555 | 3,361,267 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $95,799,080 | 3,415,297 | Shares | Sole | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||